Axcelis Tech Ord Stock Price, News & Analysis

Axcelis Technologies (Nasdaq: ACLS) reported record financial results for 2021, achieving revenue of $662.4 million, a 40% increase from 2020. Operating profit reached $127.3 million, marking a 120% growth. The fourth quarter's revenue was $205.7 million, above guidance, with a gross margin of 43.5%. Net income for 2021 was $98.7 million ($2.88 per diluted share). Additionally, the company expects first-quarter revenues of approximately $193 million with a gross margin around 43%. CEO Mary Puma emphasized strong demand and a projected revenue model of $850 million for 2022.

Axcelis Technologies (Nasdaq: ACLS) will showcase its advanced ion implanters at SEMICON Korea 2022, taking place from February 9-11 in Seoul. The company highlights its Purion H™ and XE™ series, designed for high current and energy implant applications. Additionally, Axcelis announces the first shipment from its new Asia Operations Center in Korea, enhancing its capacity to meet growing demand in the Asia Pacific region. President and CEO Mary Puma emphasized their commitment to supporting Korean chipmakers with innovative technologies.

Axcelis Technologies (Nasdaq: ACLS) announced on Feb. 1, 2022, the successful closure of a Purion Dragon™ high current evaluation tool at a leading memory manufacturer. This evaluation, completed in Q4 2021, qualifies the Purion Dragon for high-volume production of DRAM and NAND devices. The executive team expressed optimism about potential follow-on orders in 2022, highlighting the tool's ability to enhance productivity and process control in advanced memory and logic applications.

Axcelis Technologies (Nasdaq: ACLS) will release its Q4 and FY 2021 financial results on February 7, 2022, at 4:00 p.m. ET. A conference call to discuss the results will follow at 5:00 p.m. ET, accessible via an audio webcast on the Axcelis website. Interested investors can dial in using 866.588.8911 (or 707.294.1561 internationally). Axcelis, based in Beverly, Mass., specializes in ion implantation systems for the semiconductor industry.

Axcelis Technologies (Nasdaq: ACLS) announced the shipment of multiple Purion M medium current implanters and a new evaluation tool to memory device makers. These shipments occurred in Q4 2021 and Q1 2022, showcasing strong demand for the Purion M platform. Executive VP Bill Bintz highlighted the platform's flexibility and continued strength in the memory and mature process technology markets as key growth drivers for 2022.

Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of the Purion H200 SiC Power Series™ high current implanters to a major power device chipmaker in Asia and Europe during Q3 and Q4. Additionally, the company closed a Purion XE Power Series SiC high energy implanter evaluation for a new European customer. These systems will aid in high-volume production of SiC power devices for the automotive market. The SiC power device market is projected to grow at a 30% CAGR from 2019 to 2025, indicating strong demand for advanced semiconductor solutions.

Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 24th Annual Needham Virtual Growth Conference from January 10-14, 2022. Key executives, including Mary Puma and Kevin Brewer, will host a fireside chat on January 11 at 1:15 p.m. EST, with one-on-one meetings available. A live webcast of the presentation will be accessible via Axcelis' website and will be available for replay for 30 days post-event. This engagement highlights Axcelis' ongoing contributions to the semiconductor industry.

Axcelis Technologies, Inc. (Nasdaq: ACLS) has successfully completed a Purion H™ high current tool evaluation at a top advanced logic device manufacturer. This evaluation is expected to boost high-volume production capabilities for advanced logic devices. Bill Bintz, Executive VP of Product Development, emphasized the positive outlook for 2022 and 2023, citing opportunities for production buys. The Purion H features cutting-edge scanned spot beam technology that enhances device performance and yield while maintaining low operational costs.

Axcelis Technologies (NASDAQ: ACLS) announced its participation in the 10th Annual December CEO Summit on December 8, 2021, in San Francisco, CA. This event coincides with SEMICON West 2021 and involves small group meetings with 11 other companies, including ACM Research and Aehr Test. Attendance is by invitation only for accredited investors and research analysts, with a registration deadline of November 29. Presentation materials will be available on Axcelis' investor page. Proof of COVID vaccination is required for in-person attendees.